Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Flanagan

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|March 29, 2023
Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB PathwaysDenis Selimovic, Naji Kharouf, Florence Carrouel, et al.
ACS Pharmacology & Translational Science|February 15, 2024
Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 ExpressionThomas W Flanagan, Timothy P Foster, Thomas E Galbato, et al.
International Journal of Oncology|October 23, 2019
Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathwaysDenis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
International Journal of Oncology|April 30, 2026
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathwaysDenis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
Cancers|March 13, 2025
Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated MechanismsMohamed Hassan, Thomas W Flanagan, Abdulaziz M Eshaq, et al.
Cancers|January 26, 2024
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like CellsYoussef Al Hmada, Robert T Brodell, Naji Kharouf, et al.
Cells|February 9, 2024
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug ResistanceNaji Kharouf, Thomas W Flanagan, Abdulhadi A Alamodi, et al.
Cancers|August 10, 2024
Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and ResistanceAbdulaziz M Eshaq, Thomas W Flanagan, Sofie-Yasmin Hassan, et al.
International Journal of Molecular Sciences|January 11, 2025
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of OccurrenceAbdulaziz M Eshaq, Thomas W Flanagan, Abdulqader A Ba Abbad, et al.
Cells|April 27, 2026
Stemness and Survival: CD117<sup>+</sup>/CD133<sup>+</sup> Subpopulations Sustain PI3K Signaling and Drive Imatinib Resistance in Head and Neck Mucosal MelanomaSofie-Yasmin Hassan, Simeon Santourlidis, Thomas W Flanagan, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|March 29, 2023
Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB PathwaysDenis Selimovic, Naji Kharouf, Florence Carrouel, et al.
ACS Pharmacology & Translational Science|February 15, 2024
Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 ExpressionThomas W Flanagan, Timothy P Foster, Thomas E Galbato, et al.
International Journal of Oncology|October 23, 2019
Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathwaysDenis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
International Journal of Oncology|April 30, 2026
[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathwaysDenis Selimovic, Renate U Wahl, Emmanuelle Ruiz, et al.
Cancers|March 13, 2025
Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated MechanismsMohamed Hassan, Thomas W Flanagan, Abdulaziz M Eshaq, et al.
Cancers|January 26, 2024
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like CellsYoussef Al Hmada, Robert T Brodell, Naji Kharouf, et al.
Cells|February 9, 2024
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug ResistanceNaji Kharouf, Thomas W Flanagan, Abdulhadi A Alamodi, et al.
Cancers|August 10, 2024
Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and ResistanceAbdulaziz M Eshaq, Thomas W Flanagan, Sofie-Yasmin Hassan, et al.
International Journal of Molecular Sciences|January 11, 2025
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of OccurrenceAbdulaziz M Eshaq, Thomas W Flanagan, Abdulqader A Ba Abbad, et al.
Cells|April 27, 2026
Stemness and Survival: CD117<sup>+</sup>/CD133<sup>+</sup> Subpopulations Sustain PI3K Signaling and Drive Imatinib Resistance in Head and Neck Mucosal MelanomaSofie-Yasmin Hassan, Simeon Santourlidis, Thomas W Flanagan, et al.
Pageof 2